MedTrace Logo

Cryopreservation Medium With Apigenin on Post-thaw Human Sperm

NCT06560216 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2025-03-18

No results posted yet for this study

Summary

The goal of this clinical trial is to compare the effect of apigenin supplementation in freezing medium with no apigenin supplementation in freezing medium on post-thaw human sperm motility. It will also evaluate the sperm viability, total antioxidant capacity, and oxidative stress markers. The main questions it aims to answer are:

* Does apigenin supplementation in freezing medium improve the post-thaw sperm motility?
* Does apigenin supplementation in freezing medium improve the post-thaw sperm viability, total antioxidant capacity, and oxidative stress?

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Apigenin

0.2 mM in freezing medium

Sponsors & Collaborators

  • Chulalongkorn University

    lead OTHER

Principal Investigators

  • Punyawee Utaipatanacheep · Chulalongkorn University

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-28
Primary Completion
2025-02-12
Completion
2025-03-03

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06560216 on ClinicalTrials.gov